2019 Volume 45 - Canada Communicable Disease Report (CCDR)

ISSN: 1481-8531

2019 Volume 45

CCDR: Volume 45–12, December 5, 2019: HIV

• HIV in Canada—Surveillance Report, 2018
• Improving national surveillance of new HIV diagnoses
• Preventing transmission of bloodborne viruses from infected healthcare workers to patients: Summary of a new Canadian Guideline
• Accelerating our response: Government of Canada five-year action plan on sexually transmitted and blood-borne infections
• Global targets for Sexually Transmitted and Blood-Borne Infections
• Thank you to the CCDR peer reviewers of 2019
• PNAS Plus: Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis
• Work on a rapid point-of-care diagnostic test for Lyme disease

CCDR: Volume 45–11, November 7, 2019: Sexually transmitted infections among MSM

• Canadian results from the European Men-who-have-sex-with-men Internet survey (EMIS-2017)
• Newly diagnosed cases of HIV in those aged 50 years and older and those less than 50: 2008–2017
• Public health investigation of infection prevention and control complaints in Ontario, 2015–2018
• Increase in detection of Corynebacterium diphtheriae in Canada: 2006–2019
• Infectious syphilis in Canada, 2018
• Antimicrobial resistance: We are up against natural selection – the time to act is now
• Increase of XDR Typhoid fever in travellers returning from Pakistan
• Language matters: Using respectful language in relation to sexual health, substance use, STBBIs

CCDR: Volume 45–10, October 3, 2019: Open Science / Open Data

• Reaping the benefits of Open Data in public health
• Updates to the Canadian Notifiable Disease Surveillance System and its interactive website
• Community outbreak of hepatitis A disproportionately affecting men who have sex with men in Toronto, Canada, January 2017–November 2018
• A farewell and a welcome: Passing the baton
• Challenges of Open Science
• Making Open Science Work

CCDR: Volume 45-9, September 5, 2019: Outbreaks

• Use of a case–control study and control bank to investigate an outbreak of locally acquired cyclosporiasis in Canada, 2016
• Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001–2017
• Shiga toxin–producing Escherichia coli in British Columbia, 2011–2017: Analysis to inform exclusion guidelines
• Surveillance of laboratory exposures to human pathogens and toxins: Canada 2018
• Seasonal Influenza 2019–2020 NACI and AMMI Canada Recommendations, October 3, 2019

CCDR: Volume 45-7/8, July 4, 2019: Zoonotic diseases

• Surveillance of Echinococcus tapeworm in coyotes and domestic dogs in Winnipeg, Manitoba
• Human rabies postexposure prophylaxis and rabid terrestrial animals in Ontario, Canada: 2014–2016
• Toxoplasma gondii: How an Amazonian parasite became an Inuit health issue
• Epidemiology of Clostridioides difficile infection in Canada: A six-year review to support vaccine decision-making
• A public health enhanced surveillance system for a mass gathering event

CCDR: Volume 45-6, June 6, 2019: Influenza: An update

• Summary of the NACI Seasonal Influenza Vaccine Statement for 2019–2020
• Should individuals use influenza vaccine effectiveness studies to inform their decision to get vaccinated?
• Canadian pandemic influenza preparedness: Public health measures strategy
• Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016–2018
• 2018/19 influenza vaccine had low late-season effectiveness against the A(H3N2) influenza virus
• Children under 10 years of age were more affected by the influenza A(H1N1) virus in 2018/19 than in previous years

CCDR: Volume 45-5, May 2, 2019: Climate change and infectious diseases: The Solutions

• The health effects of climate change: Know the risks and become part of the solutions
• Risk assessment strategies for early detection and prediction of infectious disease outbreaks associated with climate change
• Weather-based forecasting of mosquito-borne disease outbreaks in Canada
• Using Earth observation images to inform risk assessment and mapping of climate change-related infectious diseases
• Quebec’s Multi-Party Observatory on Zoonoses and Adaptation to Climate Change

CCDR: Volume 45-4, April 4, 2019: Climate change and infectious diseases: The challenges

• Climate change and infectious diseases: What can we expect?
• Increased risk of tick-borne diseases with climate and environmental changes
• Increased risk of endemic mosquito-borne diseases in Canada due to climate change
• Could exotic mosquito-borne diseases emerge in Canada with climate change?
• How will climate change impact microbial foodborne disease in Canada?

CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea

• Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016
• Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present
• The need for integrated public health surveillance to address sexually transmitted and blood-borne syndemics
• Tuberculosis in Canada: 2017
• Canadians are still reluctant to get tested for sexually transmitted and blood-borne infections (STBBI)
• Authors’ Correction: Can Commun Dis Rep 2018;44(12)

CCDR: Volume 45-1, January 3, 2019: Challenges in infection control

• Infection prevention in personal services settings: Evidence, gaps and the way forward
• Effectiveness of hand hygiene practices in preventing influenza virus infection in the community setting: A systematic review
• Invasive group A streptococcal infection outbreaks of type emm118 in a long-term care facility, and of type emm74 in the homeless population, Montréal, Quebec
• West Nile virus illness in Ontario, Canada: 2017
• Canadian Pandemic Influenza Preparedness: Antiviral strategy
• CCDR announces new online manuscript submission capacity
• CCDR has adopted the Creative Commons CC BY 4.0 license